(Q34925449)

5 August 2017

Using medication-assisted treatment for substance use disorders: evidence of barriers and facilitators of implementation (English)

1 reference

5 August 2017

Paul M Roman

1

1 reference

PubMed ID

21377275

5 August 2017

Amanda J Abraham

series ordinal

2

1 reference

PubMed ID

21377275

5 August 2017

Hannah K Knudsen

series ordinal

3

1 reference

5 August 2017

27 January 2011

1 reference

5 August 2017

1 reference

5 August 2017

36

1 reference

5 August 2017

6

1 reference

5 August 2017

584-589

1 reference

Barriers to the implementation of medication-assisted treatment for substance use disorders: the importance of funding policies and medical infrastructure

5 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3087632

Integrating addiction medicine into graduate medical education in primary care: the time has come

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3087632

Facilitating factors and barriers to the use of medications in publicly funded addiction treatment organizations

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3087632

Early adoption of injectable naltrexone for alcohol-use disorders: findings in the private-treatment sector

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3087632

A longitudinal study of organizational formation, innovation adoption, and dissemination activities within the National Drug Abuse Treatment Clinical Trials Network

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3087632

The adoption of alcohol pharmacotherapies in the Clinical Trials Network: the influence of research network participation

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3087632

Buprenorphine adoption in the National Drug Abuse Treatment Clinical Trials Network.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3087632

Counselor attitudes toward pharmacotherapies for alcohol dependence.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3087632

A categorical typology of naltrexone-adopting private substance abuse treatment centers

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3087632

Organizational-level predictors of adoption across time: naltrexone in private substance-use disorders treatment centers.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3087632

Innovation adoption in substance abuse treatment: exposure, trialability, and the Clinical Trials Network.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3087632

Trends in the adoption of medications for alcohol dependence

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3087632

The adoption of medications in substance abuse treatment: associations with organizational characteristics and technology clusters

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3087632

Early adoption of buprenorphine in substance abuse treatment centers: data from the private and public sectors

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3087632

Buprenorphine diffusion: the attitudes of substance abuse treatment counselors

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3087632

Adoption and implementation of new technologies in substance abuse treatment.

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3087632

10.1016/J.ADDBEH.2011.01.032

26 October 2018

Identifiers

DOI

1 reference

5 August 2017

1 reference

5 August 2017

1 reference

PubMed ID

21377275